TBIO
Income statement / Annual
Last year (2023), Telesis Bio, Inc.'s total revenue was $27.51 M,
an increase of 0.27% from the previous year.
In 2023, Telesis Bio, Inc.'s net income was -$47.72 M.
See Telesis Bio, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$27.51 M |
$27.44 M |
$11.04 M |
$6.58 M |
$4.81 M |
$1.42 M |
$0.00 |
$0.00 |
| Cost of Revenue |
$10.56 M
|
$11.84 M
|
$6.74 M
|
$2.95 M
|
$8.89 M
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$16.95 M
|
$15.60 M
|
$4.30 M
|
$3.63 M
|
-$4.08 M
|
$1.42 M
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0.62
|
0.57
|
0.39
|
0.55
|
-0.85
|
1
|
0
|
0
|
| Research and Development Expenses |
$17.50 M
|
$23.46 M
|
$14.55 M
|
$8.93 M
|
$1.32 M
|
$58.02 M
|
$47.02 M
|
$15.66 M
|
| General & Administrative Expenses |
$21.09 M
|
$22.13 M
|
$14.23 M
|
$4.13 M
|
$4.69 M
|
$22.61 M
|
$14.31 M
|
$11.14 M
|
| Selling & Marketing Expenses |
$13.51 M
|
$16.49 M
|
$10.96 M
|
$6.93 M
|
$2.25 M
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$34.60 M
|
$38.62 M
|
$25.13 M
|
$11.06 M
|
$1.57 M
|
$22.61 M
|
$14.31 M
|
$11.14 M
|
| Other Expenses |
$11.39 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$63.49 M
|
$62.08 M
|
$39.67 M
|
$19.99 M
|
$2.89 M
|
$80.63 M
|
$61.33 M
|
$26.80 M
|
| Cost And Expenses |
$74.05 M
|
$73.92 M
|
$46.42 M
|
$22.94 M
|
$11.78 M
|
$80.63 M
|
$61.33 M
|
$26.80 M
|
| Interest Income |
$1.74 M
|
$738.00 K
|
$0.00
|
$0.00
|
$1.79 M
|
$1.32 M
|
$281.00 K
|
$114.00 K
|
| Interest Expense |
$3.11 M
|
$1.96 M
|
$1.37 M
|
$690.00 K
|
$1.49 M
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$4.10 M
|
$2.88 M
|
$1.57 M
|
$1.46 M
|
$857.00 K
|
$2.84 M
|
$1.59 M
|
$730.00 K
|
| EBITDA |
-$40.49 M |
-$43.62 M |
-$36.00 M |
-$15.86 M |
-$5.96 M |
-$100.12 M |
-$77.34 M |
-$25.97 M |
| EBITDA Ratio |
-1.47
|
-1.59
|
-3.26
|
-2.41
|
-1.24
|
-70.51
|
0
|
0
|
| Operating Income Ratio |
-1.69
|
-1.69
|
-3.2
|
-2.49
|
-1.45
|
-72.51
|
0
|
0
|
| Total Other Income/Expenses Net |
-$1.16 M
|
-$1.96 M
|
-$3.57 M
|
-$1.64 M
|
-$1.33 M
|
$0.00
|
$0.00
|
$0.00
|
| Income Before Tax |
-$47.70 M
|
-$48.45 M
|
-$38.94 M
|
-$18.01 M
|
-$8.30 M
|
-$102.96 M
|
-$78.92 M
|
-$26.70 M
|
| Income Before Tax Ratio |
-1.73
|
-1.77
|
-3.53
|
-2.74
|
-1.73
|
-72.51
|
0
|
0
|
| Income Tax Expense |
$24.00 K
|
$24.00 K
|
$14.00 K
|
$5.00 K
|
$0.00
|
-$5.57 M
|
-$12.48 M
|
$0.00
|
| Net Income |
-$47.72 M
|
-$48.47 M
|
-$38.96 M
|
-$18.01 M
|
-$8.30 M
|
-$97.40 M
|
-$66.44 M
|
-$26.70 M
|
| Net Income Ratio |
-1.73
|
-1.77
|
-3.53
|
-2.74
|
-1.73
|
-68.59
|
0
|
0
|
| EPS |
-1.59 |
-1.65 |
-1.33 |
-0.62 |
-0.2 |
-2.16 |
-2.23 |
-0.89 |
| EPS Diluted |
-1.59 |
-1.65 |
-1.33 |
-0.62 |
-0.2 |
-2.16 |
-2.23 |
-0.89 |
| Weighted Average Shares Out |
$29.93 M
|
$29.46 M
|
$29.32 M
|
$29.23 M
|
$40.76 M
|
$45.00 M
|
$29.86 M
|
$29.86 M
|
| Weighted Average Shares Out Diluted |
$29.93 M
|
$29.46 M
|
$29.32 M
|
$29.23 M
|
$40.76 M
|
$45.00 M
|
$29.86 M
|
$29.86 M
|
| Link |
|
|
|
|
|
|
|
|
